Suppliers / Eurofarma Laboratorios

Eurofarma Laboratorios

Brazil Updated 9 July 2026

Eurofarma Laboratorios is a finished-dose manufacturer based in Brazil. It appears in 3,199 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with ANVISA (Brazil), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by ANVISA (Brazil), INVIMA (CO) and ISP (CL). Its most recent recorded inspection, by US FDA, closed on 20 September 2022 as VAI.

0
active US DMFs
0
valid CEPs
10
registered plants 1 with an FDA FEI number
3,199
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 20 September 2022 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SAO PAULO, Brazil Not on file
ITAPEVI, Brazil Not on file
MONTES CLAROS, Brazil Not on file
RIBEIRAO PRETO, Brazil Not on file
São Paulo, Brazil Not on file
Brazil, Brazil 3009538725

4 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
ANVISA (Brazil) 2,211 11
ARCSA (EC) 414 None
MINSA (CR) 200 None
DIGEMAPS (DO) 136 None
ISP (CL) 112 1
INHRR (VE) 85 None
INVIMA (CO) None 2

Comparing suppliers?

Choose your molecules and target markets. Eurofarma Laboratorios comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 20 September 2022.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates